Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Wheatley

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
The Cochrane Database of Systematic Reviews|April 21, 2016
Bortezomib for the treatment of multiple myelomaKathleen Scott, Patrick J Hayden, Andrea Will, et al.
BMJ (Clinical Research Ed.)|April 12, 2003
Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trialsDwomoa Adu, Paul Cockwell, Natalie J Ives, et al.
Cancer Treatment Reviews|August 21, 2003
Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trialsKeith Wheatley, Natalie Ives, Barry Hancock, et al.
British Journal of Haematology|May 15, 2009
Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working PartyKeith Wheatley, Anthony H Goldstone, Tim Littlewood, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2011
Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?Carl E Clarke, Smitaa Patel, Natalie Ives, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2017
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissueJennifer E Gains, Neil J Sebire, Veronica Moroz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2013
A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastomaJayne S Wilson, Jennifer E Gains, Veronica Moroz, et al.
Blood|February 18, 2006
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trialDonald W Milligan, Keith Wheatley, Timothy Littlewood, et al.
Clinical Advances in Hematology & Oncology : H&O|September 20, 2006
Long-term results of the MRC AML10 trialAlan K Burnett, Keith Wheatley, Anthony H Goldstone, et al.
Leukemia & Lymphoma|February 18, 2011
Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendationsKai Hübel, Olaf Weingart, Frauke Naumann, et al.
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
The Cochrane Database of Systematic Reviews|April 21, 2016
Bortezomib for the treatment of multiple myelomaKathleen Scott, Patrick J Hayden, Andrea Will, et al.
BMJ (Clinical Research Ed.)|April 12, 2003
Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trialsDwomoa Adu, Paul Cockwell, Natalie J Ives, et al.
Cancer Treatment Reviews|August 21, 2003
Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trialsKeith Wheatley, Natalie Ives, Barry Hancock, et al.
British Journal of Haematology|May 15, 2009
Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working PartyKeith Wheatley, Anthony H Goldstone, Tim Littlewood, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2011
Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?Carl E Clarke, Smitaa Patel, Natalie Ives, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2017
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissueJennifer E Gains, Neil J Sebire, Veronica Moroz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2013
A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastomaJayne S Wilson, Jennifer E Gains, Veronica Moroz, et al.
Blood|February 18, 2006
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trialDonald W Milligan, Keith Wheatley, Timothy Littlewood, et al.
Clinical Advances in Hematology & Oncology : H&O|September 20, 2006
Long-term results of the MRC AML10 trialAlan K Burnett, Keith Wheatley, Anthony H Goldstone, et al.
Leukemia & Lymphoma|February 18, 2011
Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendationsKai Hübel, Olaf Weingart, Frauke Naumann, et al.
Pageof 15